TD-1211 Phase 2b Study Demonstrates Increased Bowel Movement Frequency and Constipation-Related Symptom Improvement in Patients with Opioid-Induced Constipation Ross Vickery, PhD,1 Yu-Ping Li, PhD,1 Ullrich Schwertschlag - ethers - Document - PDFSEARCH.IO

First Page	Meta Content
	TD-1211 Phase 2b Study Demonstrates Increased Bowel Movement Frequency and Constipation-Related Symptom Improvement in Patients with Opioid-Induced Constipation Ross Vickery, PhD,1 Yu-Ping Li, PhD,1 Ullrich Schwertschlag Add to Reading List Document Date: 2014-07-31 12:05:06 Open Document File Size: 501,38 KB Share Result on Facebook City South San Francisco / Pasadena / Salt Lake City / / Company PharmD1 1 Theravance Inc. / Theravance Inc. / Clinical Development Theravance Inc. / FCCP / / Event FDA Phase / / MedicalCondition pain / Opioid-Induced Constipation / Chronic opioid use / chronic opioid use Back pain / constipation / / Person Ross Vickery / Daniel Canafax / Daniel M. Canafax / / Position Vice President / / Product TD-1211 / / ProvinceOrState California / / SocialTag Alcohols Organic chemistry Ethers Morphinans Euphoriants Placebo Morphine Chemistry Medicine Phenols

TD-1211 Phase 2b Study Demonstrates Increased Bowel Movement Frequency and Constipation-Related Symptom Improvement in Patients with Opioid-Induced Constipation Ross Vickery, PhD,1 Yu-Ping Li, PhD,1 Ullrich SchwertschlagAdd to Reading List